Julie Ehlers, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com Tue, 05 Mar 2024 14:37:39 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Julie Ehlers, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com 32 32 Research Reveals More Than 275 Million Previously Unknown Genetic Variants https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/275-million-genetic-variants-previously-unknown/ Tue, 05 Mar 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116908 Corrections Issued for Papers by Dana-Farber Researchers https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/corrections-papers-dana-farber-researchers/ Tue, 05 Mar 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=116977 Belantamab Mafodotin Regimen Bests Standard Care in Rel/Ref Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/belantamab-mafodotin-multiple-myeloma-standard-care/ Thu, 15 Feb 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=116599 US Cancer Incidence Declining, but New Cancer Diagnoses May Exceed 2 Million in 2024 https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/us-cancer-incidence-declining-new-cancer-diagnoses-2-million-2024/ Tue, 23 Jan 2024 15:40:00 +0000 https://www.oncologynurseadvisor.com/?p=116142 Linking Genomic and Clinical Data Enhances Understanding of Cancer Patient Outcomes https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/genomic-clinical-data-cancer-patient-outcomes/ Wed, 17 Jan 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116056 Adding Atezolizumab to Chemo Improves Survival in Triple-Negative Breast Cancer https://www.oncologynurseadvisor.com/home/cancer-types/breast-cancer/breast-cancer-adding-atezolizumab-chemo-improves-survival-triple-negative/ Thu, 21 Dec 2023 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=114960 IV infusionAdding atezolizumab to treatment with carboplatin improved survival outcomes in patients with metastatic TNBC in a phase 2 trial.]]> High TMB Linked to Better Outcomes of ICI Therapy in Gastric Cancer https://www.oncologynurseadvisor.com/home/cancer-types/gastrointestinal-cancer/high-tmb-linked-to-better-outcomes-of-ici-therapy-in-gastric-cancer/ Tue, 05 Dec 2023 15:20:28 +0000 https://www.oncologynurseadvisor.com/?p=114459 Clear vials of medicine with blue capsPatients with gastric cancer have better outcomes of immune checkpoint inhibitor treatment if they have a high tumor mutational burden, a meta-analysis suggests. ]]> ASCO Issues Guidance for Managing “Unprecedented” Cancer Drug Shortages https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/asco-guidance-cancer-drug-shortages/ Wed, 22 Nov 2023 15:50:00 +0000 https://www.oncologynurseadvisor.com/?p=114260 Pharmacist finding medication (Photo By BSIP/UIG Via Getty Images)ASCO has released guidelines on how to treat patients amid current cancer drug shortages. ]]> Use of Palliative Care in Metastatic Breast Cancer Varies by Race/Ethnicity https://www.oncologynurseadvisor.com/home/cancer-types/breast-cancer/use-of-palliative-care-in-metastatic-breast-cancer-varies-by-race-ethnicity/ Tue, 10 Oct 2023 14:30:00 +0000 https://www.oncologynurseadvisor.com/?p=111082 black older woman at home on couch wearing headscarfNew research suggests that, in the United States, the use of palliative care for metastatic breast cancer varies by race.]]> AI Chatbots Can Provide Accurate Cancer Information but Have Limitations https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/ai-chatbots-can-provide-accurate-cancer-information-but-have-limitations/ Wed, 30 Aug 2023 14:30:00 +0000 https://www.oncologynurseadvisor.com/?p=110191 A woman’s hand is asking an AI chatbot pre-typed questions and the Artificial Intelligence website is answering.AI chatbots can sometimes provide accurate information about cancers, but these tools have significant limitations, according to researchers.]]>